A team of West Australian researchers have tested a ground-breaking new treatment for those with high-blood pressure, one of the world’s leading causes of death, thanks to the support of the Royal Perth Hospital Research Foundation.

In honour of World Pancreatic Cancer Day, we would like to highlight the work of Miss Arunima Panda, funded by the RPH Research Foundation.

Springboard Plus supports Early and Mid-Career researchers who are translating their ideas into clinical practice that could lead to a significant impact on the health and wellbeing of our community.

Thank you for joining us at the RPH Research Foundation's Research Symposium and Awards Day 2022 where we celebrated the brightest minds of WA.

Every year the Cardiac Society of Australia and New Zealand (CSANZ) presents the R T Hall Prize. The RT Hall Prize is the most prestigious research award of CSANZ and recognises the achievements of senior and established investigators. This year, Professor Gerald Watts has been awarded the Prize at the 70th Annual Scientific Meeting of CSANZ last month.

Dr Chi Le-Ha was the lead investigator of this world first study that showed young adults who had higher testosterone levels in their umbilical cord blood at birth tended to have high blood pressure by 20 to 27 years of age.

Our Springboard Grant Recipients have found biomarkers that can distinguish anaphylaxis from other forms of shock.

Australian researchers have developed an innovative, new treatment for one of the world’s biggest health concerns – high blood pressure.

Research led by a team at Royal Perth Hospital is setting a new gold standard for the treatment of collapsed lungs.

This has certainly proved true for the participants of Associate Professor Kay Cox’s Sedentary Women Exercise Adherence Trial (SWEAT), who reunited to celebrate the 21st anniversary of the study’s launch.

A new study indicates almost 60 per cent of Australians who have high blood pressure are not receiving medical treatment for the condition, and some may not even know they have high blood pressure.

RPH Research Foundation’s new Career Advancement Fellowships program is providing more than $1 million in funding to help six of WA’s brightest researchers discover the answers to important health questions.

Perth nurse receives medical research funding to help fight a life-threatening illness that kills more people than breast cancer and prostate cancer combined.

Resident Researcher Professor Markus Schlaich from the Dobney Hypertension Centre is working hard to find out.

RPH Research Foundation is funding a world-first, randomised clinical trial to investigate if using hearing aids is an effective way to improve the cognitive functions of older adults and delay the onset of dementia symptoms.

A third of adult Australians have high blood pressure (hypertension), but only half of them are aware they have this potentially life-threatening condition. Plus, the standard medications prescribed to treat hypertension don’t control BP in almost 60 per cent of patients.

During NAIDOC Week the Aboriginal Ageing Well Research team at The University of Western Australia (with the support of RPH Research Foundation) focuses on a tough subject: Dementia.

3D Printing, Scanning, and Stem cell therapy to heal complex wounds

We’re thrilled to announce trailblazing researchers, Dr Alan Kop and Dr Andrew Ford, are the winners of the Foundation’s inaugural Innovation and Impact Grants.

Researchers at RPH Research Foundation have discovered evidence that breast arterial calcification (BAC), an incidental finding on up to almost a third of mammograms, could potentially help screen for other preventable conditions, including coronary artery disease (CAD), high blood pressure (hypertension) and diabetes mellitus.